MedTrace Logo

NEMO - an App for Side Effect Management in Oncology

NCT04493450 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2020-08-03

No results posted yet for this study

Summary

This study investigates the use of digital and standardized documentation by patients of frequently occurring adverse events in oncological therapies.

Conditions

  • Cancer Patients

Interventions

OTHER

Documentation of cancer treatment side effects

Standardized documentation of occurred side effects

Sponsors & Collaborators

  • Thomas Seufferlein

    lead OTHER

Principal Investigators

  • Seufferlein · University Hospital Ulm

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2021-12-31
Completion
2022-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04493450 on ClinicalTrials.gov